Screen to Save 2: Rural Cancer Screening Educational Intervention
Cancer, Colorectal Cancer, Lung Cancer
About this trial
This is an interventional screening trial for Cancer focused on measuring cancer, cancer screening, colorectal cancer, lung cancer, education, rural, lung cancer screening, tobacco
Eligibility Criteria
Inclusion Criteria for study arms 1-4:
- Resident of one of the RUCC 7-9 counties in New Hampshire or Vermont (Coos or Sullivan County, NH; Caledonia, Windsor, Windham, Orange, Orleans, Lamoille, or Essex County, VT) and
- Age 45-74 at the time of enrollment in the study
Additional Inclusion Criteria for study arm 4:
- Any New Hampshire or Vermont residents age 45-75
Exclusion Criteria:
- Cognitive impairment preventing participation in informed consent process
Three-Month Follow-Up Survey Inclusion Criteria:
A participant will be eligible for inclusion in the three-month follow-up survey if the participant completed the pre-test, educational intervention, and post-test (in-person or through online submission) and at the time of initial participation:
- Answered a colorectal cancer screening history question indicating that the participant has never received colorectal cancer screening OR does not know if he/she has received colorectal cancer screening previously OR
- Answered a series of questions indicating that the participant received prior colorectal cancer screening but may be overdue for colorectal cancer screening based on the type of colorectal cancer screening last reported and screening guidelines for the frequency of re-screening.
Six-Month Follow-Up Survey Inclusion Criteria:
A participant will be eligible for inclusion in the six-month follow-up survey if the participant participated in the three-month-follow up survey and at that time reported that having:
- A FIT/FOBT screening or Cologuard (stool) screening performed since the time of initial study participation, but having not received the results
- An abnormal FIT/FOBT, or Cologuard (stool) screening since the time of initial study participation, but had not received a diagnostic colonoscopy
- A colonoscopy since the time of initial study participation, but had not received the final results
Sites / Locations
- Dartmouth Cancer Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Experimental Arm 1
Experimental Arm 2
Experimental Arm 3
Experimental Arm 4
Attendees at in-person events (e.g. health fairs) who meet eligibility criteria will be able to enroll and participate in-person, with some participating in online or telephone survey follow-up.
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via an age and geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online or telephone follow-up.
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via an age and geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online or telephone follow-up. This arms will serve as an experimental arm for assessing study aim 2 and as a control arm for study aim 1.
Patients identified by one or more healthcare systems to be due or overdue for colorectal cancer screening will be informed by their healthcare provider or healthcare system (e.g. via the healthcare system's patient portal) that they are due for screening and will be informed how to schedule an colorectal cancer screening related appointment (e.g. discussion with primary care provider about colorectal cancer screening options) along with the option to receive education about colorectal cancer screening. Patients who are interested in receiving education may view the education with or without participating in the research study. Patients who elect to be study participants will participate in consenting, eligibility screening, pre-test, post-test, and possible three- and six-month using a parallel structure to study arms two and three.